455 related articles for article (PubMed ID: 15451329)
1. Contraceptive efficacy and safety of DMPA-SC.
Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
[TBL] [Abstract][Full Text] [Related]
3. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
4. Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL.
Westhoff C; Jain JK; Milsom I; Ray A
Contraception; 2007 Apr; 75(4):261-7. PubMed ID: 17362703
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception.
Cameron ST; Glasier A; Johnstone A
Contraception; 2012 May; 85(5):458-64. PubMed ID: 22079602
[TBL] [Abstract][Full Text] [Related]
6. The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review.
Dragoman MV; Gaffield ME
Contraception; 2016 Sep; 94(3):202-15. PubMed ID: 26874275
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
8. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
Aktun H; Moroy P; Cakmak P; Yalcin HR; Mollamahmutoglu L; Danisman N
Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
[TBL] [Abstract][Full Text] [Related]
9. Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously.
Segall-Gutierrez P; Taylor D; Liu X; Stanzcyk F; Azen S; Mishell DR
Contraception; 2010 Jun; 81(6):487-95. PubMed ID: 20472115
[TBL] [Abstract][Full Text] [Related]
10. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.
Kaunitz AM
Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206
[TBL] [Abstract][Full Text] [Related]
11. Preference for Sayana® Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.
Polis CB; Nakigozi GF; Nakawooya H; Mondo G; Makumbi F; Gray RH;
Contraception; 2014 May; 89(5):385-95. PubMed ID: 24332432
[TBL] [Abstract][Full Text] [Related]
12. Depot-medroxyprogesterone acetate: an update.
Bakry S; Merhi ZO; Scalise TJ; Mahmoud MS; Fadiel A; Naftolin F
Arch Gynecol Obstet; 2008 Jul; 278(1):1-12. PubMed ID: 18470526
[TBL] [Abstract][Full Text] [Related]
13. New aspects of injectable contraception.
Phillips OP
Int J Fertil Womens Med; 2001; 46(1):31-6. PubMed ID: 11294618
[TBL] [Abstract][Full Text] [Related]
14. Experience with the use of depo-medroxyprogesterone acetate in a Nigerian population.
Falase EA; Otolorin EO; Ladipo OA
Afr J Med Med Sci; 1988 Dec; 17(4):209-13. PubMed ID: 2854367
[TBL] [Abstract][Full Text] [Related]
15. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg.
Arias RD; Jain JK; Brucker C; Ross D; Ray A
Contraception; 2006 Sep; 74(3):234-8. PubMed ID: 16904417
[TBL] [Abstract][Full Text] [Related]
16. Long-acting hormonal contraception: assessing impact on bone density, weight, and mood.
Kaunitz AM
Int J Fertil Womens Med; 1999; 44(2):110-7. PubMed ID: 10338269
[TBL] [Abstract][Full Text] [Related]
17. Long-acting contraceptive options.
Kaunitz AM
Int J Fertil Menopausal Stud; 1996; 41(2):69-76. PubMed ID: 8829701
[TBL] [Abstract][Full Text] [Related]
18. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception.
Nelson AL
J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701
[TBL] [Abstract][Full Text] [Related]
19. Depo-Provera use in an Australian metropolitan practice.
Fraser IS; Dennerstein GJ
Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
[TBL] [Abstract][Full Text] [Related]
20. Current options for injectable contraception in the United States.
Kaunitz AM
Semin Reprod Med; 2001 Dec; 19(4):331-7. PubMed ID: 11727175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
